Charlotte C Ronveaux1, Guillaume de Lartigue2, Helen E Raybould3. 1. Dept. of Anatomy, Physiology and Cell Biology, UC Davis School of Veterinary Medicine, Davis, CA 95616, USA; AgroParisTech, UMR914 Nutrition Physiology and Ingestive Behavior, Paris 75005, France. 2. Dept. of Anatomy, Physiology and Cell Biology, UC Davis School of Veterinary Medicine, Davis, CA 95616, USA. 3. Dept. of Anatomy, Physiology and Cell Biology, UC Davis School of Veterinary Medicine, Davis, CA 95616, USA. Electronic address: heraybould@ucdavis.edu.
Abstract
UNLABELLED: Gut-derived glucagon like peptide-1 (GLP-1) acts in the postprandial period to stimulate insulin secretion and inhibit gastrointestinal motor and secretory function; whether endogenous peripheral GLP-1 inhibits food intake is less clear. We hypothesized that GLP-1 inhibits food intake in the fed, but not fasted, state. There is evidence that GLP-1 acts via stimulation of vagal afferent neurons (VAN); we further hypothesized that the satiating effects of endogenous GLP-1 in the postprandial period is determined either by a change in GLP-1 receptor (GLP-1R) expression or localization to different cellular compartments in VAN. METHODS: Food intake was recorded following administration of GLP-1 (50μg/kg or 100μg/kg) or saline (IP) in Wistar rats fasted for 18h or fasted then re-fed with 3g chow. GLP-1R protein expression and localization on VAN were determined by immunocytochemistry and immunoblots in animals fasted for 18h or fasted then re-fed for 40min. GLP-1R mRNA level was detected in animals fasted for 18h or fasted and re-fed ad libitum for 2h. RESULTS: GLP-1 (100μg/kg) significantly reduced 40min food intake by 38% in re-fed but not fasted rats (p<0.05). GLP-1R mRNA or protein levels in VAN were unchanged in re-fed compared to fasted rats. However, GLP-1R localization to the plasma membrane was significantly increased in VAN by feeding. CONCLUSION: Feeding changes the ability of peripheral GLP-1 to inhibit food intake. GLP-1Rs are trafficked to the plasma membrane in response to a meal. GLP-1 may play a role in regulating food intake in the postprandial period.
UNLABELLED: Gut-derived glucagon like peptide-1 (GLP-1) acts in the postprandial period to stimulate insulin secretion and inhibit gastrointestinal motor and secretory function; whether endogenous peripheral GLP-1 inhibits food intake is less clear. We hypothesized that GLP-1 inhibits food intake in the fed, but not fasted, state. There is evidence that GLP-1 acts via stimulation of vagal afferent neurons (VAN); we further hypothesized that the satiating effects of endogenous GLP-1 in the postprandial period is determined either by a change in GLP-1 receptor (GLP-1R) expression or localization to different cellular compartments in VAN. METHODS: Food intake was recorded following administration of GLP-1 (50μg/kg or 100μg/kg) or saline (IP) in Wistar rats fasted for 18h or fasted then re-fed with 3g chow. GLP-1R protein expression and localization on VAN were determined by immunocytochemistry and immunoblots in animals fasted for 18h or fasted then re-fed for 40min. GLP-1R mRNA level was detected in animals fasted for 18h or fasted and re-fed ad libitum for 2h. RESULTS:GLP-1 (100μg/kg) significantly reduced 40min food intake by 38% in re-fed but not fasted rats (p<0.05). GLP-1R mRNA or protein levels in VAN were unchanged in re-fed compared to fasted rats. However, GLP-1R localization to the plasma membrane was significantly increased in VAN by feeding. CONCLUSION: Feeding changes the ability of peripheral GLP-1 to inhibit food intake. GLP-1Rs are trafficked to the plasma membrane in response to a meal. GLP-1 may play a role in regulating food intake in the postprandial period.
Authors: Nicola M Neary; Caroline J Small; Maralyn R Druce; Adrian J Park; Sandra M Ellis; Nina M Semjonous; Catherine L Dakin; Karin Filipsson; Fang Wang; Aysha S Kent; Gary S Frost; Mohammad A Ghatei; Stephen R Bloom Journal: Endocrinology Date: 2005-09-08 Impact factor: 4.736
Authors: Samara L Freeman; Jorg Glatzle; Carla S Robin; Melissa Valdellon; Catia Sternini; James W Sharp; Helen E Raybould Journal: Gastroenterology Date: 2006-07 Impact factor: 22.682
Authors: V Bucinskaite; T Tolessa; J Pedersen; B Rydqvist; L Zerihun; J J Holst; P M Hellström Journal: Neurogastroenterol Motil Date: 2009-05-13 Impact factor: 3.598
Authors: Elisabeth B Rüttimann; Myrtha Arnold; Jacquelien J Hillebrand; Nori Geary; Wolfgang Langhans Journal: Endocrinology Date: 2008-10-23 Impact factor: 4.736
Authors: Torsten P Vahl; Miyuki Tauchi; Timothy S Durler; Eileen E Elfers; Timothy M Fernandes; Ronald D Bitner; Kay S Ellis; Stephen C Woods; Randy J Seeley; James P Herman; David A D'Alessio Journal: Endocrinology Date: 2007-06-21 Impact factor: 4.736
Authors: Galina Burdyga; Guillaume de Lartigue; Helen E Raybould; Richard Morris; Rod Dimaline; Andrea Varro; David G Thompson; Graham J Dockray Journal: J Neurosci Date: 2008-11-05 Impact factor: 6.167
Authors: Ronald P Gaykema; Brandon A Newmyer; Matteo Ottolini; Vidisha Raje; Daniel M Warthen; Philip S Lambeth; Maria Niccum; Ting Yao; Yiru Huang; Ira G Schulman; Thurl E Harris; Manoj K Patel; Kevin W Williams; Michael M Scott Journal: J Clin Invest Date: 2017-02-20 Impact factor: 14.808
Authors: Yolanda Diz-Chaves; Salvador Herrera-Pérez; Lucas C González-Matías; José Antonio Lamas; Federico Mallo Journal: Nutrients Date: 2020-10-28 Impact factor: 5.717